Last reviewed · How we verify
NCT06770816: ESP-LV ECHO
Effect of Left Erector Spinae Plane Block on Left Ventricular Functions
trial testing Echocardiography in Erector Spina Plan Block in 23 participants. Not yet recruiting.
2 January 2026
Quick facts
| Lead sponsor | Aydin Adnan Menderes University |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 23 |
| Start date | 10 January 2025 |
| Primary completion | 2 January 2026 |
| Estimated completion | 2 February 2026 |
Drugs / interventions tested
- Echocardiography
Conditions studied
- Erector Spina Plan Block — all drugs for Erector Spina Plan Block →
- Echocardiography — all drugs for Echocardiography →
Sponsor
Aydin Adnan Menderes University
Who can join
Adults 18 to 75, any sex, with Erector Spina Plan Block or Echocardiography. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Many studies have shown a decrease in inotropic status (intrinsic function) after blockade of cardiac sympathetic innervation with thoracic epidural anesthesia (TEA) (4,5). There is no study in the literature investigating the cardiac effects of left thoracic ESP block. We think that left thoracic ESP block, like TEA, may also have cardiac effects. Therefore, we aimed to investigate the effect of left thoracic ESP block on left ventricular functions with transthoracic echocardiography (TTE).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06770816
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Echocardiography
Trials testing the same drug.
- NCT06863402 — Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype · Phase 2 · recruiting
- NCT07372859 — Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female · NA · not yet recruiting
- NCT06434064 — Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advan · Phase 2 · recruiting
- NCT06871410 — Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia · Phase 1 · recruiting
- NCT07375433 — Heart Failure With Preserved Ejection Fraction in Patients With Сhronic Obstructive Pulmonary Disease: Clinical Course a · recruiting
Other recruiting trials for Erector Spina Plan Block
Currently open trials in the same condition.
- NCT07377877 — External Oblique Intercostal Block vs Erector Spinae Plane Block for Postoperative Analgesia After Laparoscopic Cholecys · NA · recruiting
- NCT06933498 — Effects of Erector Spinae Plane Block on Opioid Consumption, Anesthetic Consumption and Hemodynamics in Lumbar Disc Hern · NA · recruiting
- NCT06857331 — Perioperative Analgesia With Erector Spinae Plane Block in Liver Transplant Recipients · NA · recruiting
Other Aydin Adnan Menderes University trials
Trials by the same sponsor.
- NCT07535151 — The Study Aims to Determine the Effect of Using Animal-shaped Magic Mirrors During Vaccination in Children Aged 1-4 Year · not yet recruiting
- NCT07448246 — Effect of Bilateral Rhomboid Intercostal Block on Postoperative Pain After Breast Implant Surgery · NA · recruiting
- NCT07317492 — HEMOVAR Study on Hemorrhoids and Varicose Veins · recruiting
- NCT07121699 — The Role of Left Ventricular Outflow Tract (LVOT) Velocity-time Integral (VTI) and Respiratory Variability at Peak Rate · not yet recruiting
- NCT07044739 — Information on the Use of Anti-embolic Stockings in Patients Undergoing Vein Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06770816 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aydin Adnan Menderes University
- Last refreshed: 13 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06770816.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing